US3843662A
(en)
|
1971-12-09 |
1974-10-22 |
Pfizer |
2-halo-5-(substituted piperidino sulfonyl)benzoic acids
|
AU1508183A
(en)
|
1982-06-04 |
1983-12-08 |
Beecham Group Plc |
Benzamide and anilide derivatives of 8-azabicyclo-(3.2.1)- -octane
|
EP0135545A1
(en)
|
1983-02-19 |
1985-04-03 |
Beecham Group Plc |
Azabicycloalkyl benzamide and anilide derivatives
|
JPS62142164A
(ja)
|
1985-12-13 |
1987-06-25 |
Ishihara Sangyo Kaisha Ltd |
4,5−ジクロロイミダゾ−ル系化合物及びそれらを含有する有害生物防除剤
|
IN164880B
(pt)
|
1986-01-30 |
1989-06-24 |
Ishihara Sangyo Kaisha |
|
US5272167A
(en)
|
1986-12-10 |
1993-12-21 |
Schering Corporation |
Pharmaceutically active compounds
|
CA1339133C
(en)
|
1987-03-13 |
1997-07-29 |
Rikuo Nasu |
Imidazole compounds and biocidal composition comprising the same for controlling harmful organisms
|
US5571821A
(en)
|
1993-05-20 |
1996-11-05 |
Texas Biotechnology Corporation |
Sulfonamides and derivatives thereof that modulate the activity of endothelin
|
GB8904174D0
(en)
|
1989-02-23 |
1989-04-05 |
British Bio Technology |
Compounds
|
US4962101A
(en)
|
1989-08-21 |
1990-10-09 |
Merck & Co., Inc. |
2-(Heterocyclylalkyl)phenyl carbapenem antibacterial agents
|
GB9023082D0
(en)
|
1990-10-24 |
1990-12-05 |
Schering Agrochemicals Ltd |
Fungicides
|
GB9109557D0
(en)
|
1991-05-02 |
1991-06-26 |
Wellcome Found |
Chemical compounds
|
US5308826A
(en)
|
1993-04-22 |
1994-05-03 |
Zeneca Limited |
Herbicidal 4-substituted pyridyl-3-carbinols
|
GB9405347D0
(en)
|
1994-03-18 |
1994-05-04 |
Agrevo Uk Ltd |
Fungicides
|
AU2534295A
(en)
|
1994-05-27 |
1995-12-21 |
James Black Foundation Limited |
Gastrin and cck antagonists
|
US5795907A
(en)
|
1994-05-27 |
1998-08-18 |
James Black Foundation Limited |
Gastin and CCK receptor ligands
|
US5763618A
(en)
|
1995-05-12 |
1998-06-09 |
Konica Corporation |
Manufacturing method of sulfides
|
US5723411A
(en)
|
1995-10-31 |
1998-03-03 |
E. I. Du Pont De Nemours And Company |
Herbicidal pyridazinones
|
DE19540995A1
(de)
|
1995-11-03 |
1997-05-07 |
Hoechst Ag |
Substituierte Sulfonimidamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
|
GB9612884D0
(en)
|
1996-06-20 |
1996-08-21 |
Smithkline Beecham Plc |
Novel compounds
|
JP2000512646A
(ja)
|
1996-06-25 |
2000-09-26 |
スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー |
5ht7受容体アンタゴニストとしてのスルホンアミド誘導体
|
WO1998023285A1
(en)
|
1996-11-29 |
1998-06-04 |
Smithkline Beecham Plc |
Use of a combination of penciclovir and alpha-interferon in the manufacture of a medicament for the treatment of hepatitis b
|
US5939423A
(en)
|
1997-04-16 |
1999-08-17 |
Sciclone Pharmaceuticals, Inc. |
Treatment of hepatitis B infection with thymosin alpha 1 and famciclovir
|
US5919970A
(en)
|
1997-04-24 |
1999-07-06 |
Allergan Sales, Inc. |
Substituted diaryl or diheteroaryl methanes, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activity
|
US5994396A
(en)
|
1997-08-18 |
1999-11-30 |
Centaur Pharmaceuticals, Inc. |
Furansulfonic acid derivatives and pharmaceutical compositions containing the same
|
JP4253126B2
(ja)
|
1998-01-29 |
2009-04-08 |
アムジェン インコーポレイテッド |
Ppar−ガンマ調節剤
|
WO1999048492A1
(fr)
|
1998-03-26 |
1999-09-30 |
Japan Tobacco Inc. |
Derives d'amide et antagonistes de nociceptine
|
US6251893B1
(en)
|
1998-06-15 |
2001-06-26 |
Nps Allelix Corp. |
Bicyclic piperidine and piperazine compounds having 5-HT6 receptor affinity
|
BR0007527B1
(pt)
|
1999-01-15 |
2011-12-27 |
|
fenilfenantridinas com atividade inibitària de pde-iv, seu uso, bem como medicamento compreendendo as mesmas.
|
WO2001005390A2
(en)
|
1999-07-16 |
2001-01-25 |
Warner-Lambert Company |
Method for treating chronic pain using mek inhibitors
|
ATE382351T1
(de)
|
1999-08-10 |
2008-01-15 |
Univ Oxford |
Langkettige n-alkyl verbindungen und deren oxa- derivate zur verwendung als anitvirale mittel
|
WO2001019788A2
(en)
|
1999-09-17 |
2001-03-22 |
Cor Therapeutics, Inc. |
BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa
|
PE20010628A1
(es)
|
1999-10-01 |
2001-06-18 |
Takeda Chemical Industries Ltd |
Compuestos de amina ciclica, su produccion y su uso
|
KR20020067050A
(ko)
|
1999-12-28 |
2002-08-21 |
화이자 프로덕츠 인코포레이티드 |
염증성, 자기면역 및 호흡기 질환의 치료에 유용한브이엘에이-4 의존성 세포 결합의 비펩티드계 억제제
|
AU2882801A
(en)
|
2000-01-28 |
2001-08-07 |
Kaken Pharmaceutical Co., Ltd. |
Azepine derivatives
|
US6511980B2
(en)
|
2000-05-05 |
2003-01-28 |
Ortho Mcneil Pharmaceutical, Inc. |
Substituted diamine derivatives useful as motilin antagonists
|
EP1193268A1
(en)
|
2000-09-27 |
2002-04-03 |
Applied Research Systems ARS Holding N.V. |
Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein Junkinases
|
WO2002051410A2
(en)
|
2000-12-22 |
2002-07-04 |
Akzo Nobel N.V. |
Phenylthiazole and thiazoline derivatives and their use as antiparasitics
|
CN1247582C
(zh)
|
2000-12-27 |
2006-03-29 |
大日本住友制药株式会社 |
新的碳代青霉烯化合物
|
AU2002248418A1
(en)
|
2001-02-09 |
2002-08-28 |
Massachusetts Institute Of Technology |
Methods of identifying agents that mediate polypeptide aggregation
|
US6650463B2
(en)
|
2001-03-13 |
2003-11-18 |
Seiko Epson Corporation |
Electrophoretic display device
|
KR100713137B1
(ko)
|
2001-06-28 |
2007-05-02 |
동화약품공업주식회사 |
신규의 2,4-디플루오로벤즈아미드 유도체
|
AU2002317377A1
(en)
|
2001-07-20 |
2003-03-03 |
Cancer Research Technology Limited |
Biphenyl apurinic/apyrimidinic site endonuclease inhibitors to treat cancer
|
DE10136043A1
(de)
|
2001-07-25 |
2003-02-13 |
Degussa |
Verfahren zur Herstellung von modifiziertem Ruß
|
US6956035B2
(en)
|
2001-08-31 |
2005-10-18 |
Inotek Pharmaceuticals Corporation |
Isoquinoline derivatives and methods of use thereof
|
JP2005514366A
(ja)
|
2001-11-20 |
2005-05-19 |
イーライ・リリー・アンド・カンパニー |
3−置換オキシインドールβ3アゴニスト
|
SE0201635D0
(sv)
|
2002-05-30 |
2002-05-30 |
Astrazeneca Ab |
Novel compounds
|
CA2487891A1
(en)
|
2002-06-05 |
2003-12-18 |
Institute Of Medicinal Molecular Design, Inc. |
Inhibitors against the activation of ap-1 and nfat
|
CN1678311A
(zh)
|
2002-06-27 |
2005-10-05 |
诺沃挪第克公司 |
用作治疗剂的芳基羰基衍生物
|
MXPA05000130A
(es)
|
2002-06-27 |
2005-02-17 |
Novo Nordisk As |
Derivados de aril-carbonilo como agentes terapeuticos.
|
WO2004011427A2
(en)
|
2002-07-31 |
2004-02-05 |
Smithkline Beecham Corporation |
Substituted benzanilides as modulators of the ccr5 receptor
|
AU2003256923A1
(en)
|
2002-07-31 |
2004-02-16 |
Smithkline Beecham Corporation |
Substituted benzanilides as modulators of the ccr5 receptor
|
US7186735B2
(en)
|
2002-08-07 |
2007-03-06 |
Sanofi-Aventis Deutschland Gmbh |
Acylated arylcycloalkylamines and their use as pharmaceuticals
|
US7338956B2
(en)
|
2002-08-07 |
2008-03-04 |
Sanofi-Aventis Deutschland Gmbh |
Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals
|
JP4399862B2
(ja)
|
2002-08-09 |
2010-01-20 |
味の素株式会社 |
腸疾患および内臓痛の治療薬
|
US20040110802A1
(en)
|
2002-08-23 |
2004-06-10 |
Atli Thorarensen |
Antibacterial benzoic acid derivatives
|
US7504426B2
(en)
|
2002-09-06 |
2009-03-17 |
Janssen Pharmaceutica N.V. |
Heterocyclic compounds
|
SE0202838D0
(sv)
|
2002-09-24 |
2002-09-24 |
Astrazeneca Ab |
Chemical compounds
|
US7378525B2
(en)
|
2002-12-23 |
2008-05-27 |
Millennium Pharmaceuticals, Inc. |
CCR8 inhibitors
|
US7320989B2
(en)
|
2003-02-28 |
2008-01-22 |
Encysive Pharmaceuticals, Inc. |
Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists
|
ES2378620T3
(es)
|
2003-03-27 |
2012-04-16 |
Cytokinetics, Inc. |
Sulfonamidas para el tratamiento de insuficiencia cardiaca congestiva, sus composiciones y usos.
|
JP2006525366A
(ja)
|
2003-04-30 |
2006-11-09 |
ジ インスチチュート フォー ファーマシューティカル ディスカバリー、エルエルシー |
複素環式カルボン酸置換基
|
WO2004100947A2
(en)
|
2003-05-06 |
2004-11-25 |
Smithkline Beecham Corporation |
Novel chemical compounds
|
MXPA05012268A
(es)
|
2003-05-13 |
2006-02-10 |
Schering Corp |
N-arilsulfonilpiperidinas enlazadas como inhibidores de la gamma-secretasa.
|
EP1651595A2
(en)
|
2003-05-30 |
2006-05-03 |
Rigel Pharmaceuticals, Inc. |
Ubiquitin ligase inhibitors
|
US20110275630A1
(en)
|
2003-06-02 |
2011-11-10 |
Abbott Laboratories |
Isoindolinone kinase inhibitors
|
WO2005000231A2
(en)
|
2003-06-06 |
2005-01-06 |
Smithkline Beecham Corporation |
Il-8 receptor antagonists
|
AR045047A1
(es)
|
2003-07-11 |
2005-10-12 |
Arena Pharm Inc |
Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
|
GB0319151D0
(en)
|
2003-08-14 |
2003-09-17 |
Glaxo Group Ltd |
Novel compounds
|
US8084457B2
(en)
|
2003-09-15 |
2011-12-27 |
Lead Discovery Center Gmbh |
Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases
|
GB0325956D0
(en)
|
2003-11-06 |
2003-12-10 |
Addex Pharmaceuticals Sa |
Novel compounds
|
US7498050B2
(en)
|
2003-12-15 |
2009-03-03 |
Kraft Foods Global Brands Llc |
Edible spread composition and packaged product
|
DE102004009238A1
(de)
|
2004-02-26 |
2005-09-08 |
Merck Patent Gmbh |
Arylamid-Derivate
|
US8404747B2
(en)
|
2004-03-05 |
2013-03-26 |
The General Hospital Corporation |
Compositions and methods for modulating interaction between polypeptides
|
US20080113944A1
(en)
|
2004-05-04 |
2008-05-15 |
Novo Nordisk A/S |
Novel Indole Derivatives
|
WO2005115374A1
(en)
|
2004-05-29 |
2005-12-08 |
7Tm Pharma A/S |
Crth2 receptor ligands for therapeutic use
|
WO2006002133A1
(en)
|
2004-06-22 |
2006-01-05 |
Schering Corporation |
Cannabinoid receptor ligands
|
PL1773768T3
(pl)
|
2004-07-30 |
2019-03-29 |
Exelixis, Inc. |
Pochodne pirolu jako środki farmaceutyczne
|
DE102004042441A1
(de)
|
2004-08-31 |
2006-04-06 |
Sanofi-Aventis Deutschland Gmbh |
Mit Aminosäuren substituierte Hexahydro-pyrazino(1,2-a)pyrimidin-4,7-dionderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
BRPI0514691A
(pt)
|
2004-08-31 |
2008-06-17 |
Astrazeneca Ab |
composto ou um sal farmaceuticamente aceitável do mesmo, processo para preparar o mesmo, composição farmacêutica, e, uso de um composto ou um sal farmaceuticamente aceitável do mesmo
|
AU2005295788A1
(en)
|
2004-10-13 |
2006-04-27 |
Wyeth |
N-benzenesulfonyl substituted anilino-pyrimidine analogs
|
US8008335B2
(en)
|
2004-10-19 |
2011-08-30 |
Novartis Vaccines And Diagnostics, Inc. |
Indole and benzimidazole derivatives
|
TW200628463A
(en)
|
2004-11-10 |
2006-08-16 |
Synta Pharmaceuticals Corp |
Heteroaryl compounds
|
US20060122236A1
(en)
|
2004-12-06 |
2006-06-08 |
Wood Michael R |
Substituted biaryl-carboxylate derivatives
|
AR054183A1
(es)
|
2004-12-22 |
2007-06-06 |
Astrazeneca Ab |
Derivados de piridincarboxamida y su uso como agentes anticancerigenos. procesos de obtencion y composiciones farmaceuticas.
|
WO2006067445A2
(en)
|
2004-12-22 |
2006-06-29 |
Astrazeneca Ab |
Csf-1r kinase inhibitors
|
FI117653B
(fi)
|
2005-02-21 |
2006-12-29 |
Eigenor Oy |
Menetelmä ja laitteisto liikkuvien kohteiden havaitsemiseksi tutkalla
|
GB0510141D0
(en)
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds B3
|
WO2006128129A2
(en)
|
2005-05-26 |
2006-11-30 |
Synta Pharmaceuticals Corp. |
Method for treating cancer
|
US20070032493A1
(en)
|
2005-05-26 |
2007-02-08 |
Synta Pharmaceuticals Corp. |
Method for treating B cell regulated autoimmune disorders
|
US7790726B2
(en)
|
2005-08-16 |
2010-09-07 |
Chemocentryx, Inc. |
Monocyclic and bicyclic compounds and methods of use
|
RS51470B
(en)
|
2005-09-16 |
2011-04-30 |
Arrow Therapeutics Limited |
BIPHENYL DERIVATIVES AND THEIR USE FOR THE TREATMENT OF HEPATITIS C
|
CA2633541A1
(en)
|
2005-12-12 |
2007-06-21 |
Genelabs Technologies, Inc. |
N-(6-membered aromatic ring)-amido anti-viral compounds
|
MX2008008340A
(es)
|
2005-12-21 |
2008-09-03 |
Schering Corp |
Tratamiento de enfermedad de higado graso no alcoholica usando agentes reductores de colesterol y/o antagonista/agonista inverso de receptor de histamina 3.
|
EP1981849A1
(en)
|
2005-12-29 |
2008-10-22 |
LEK Pharmaceuticals D.D. |
Heterocyclic compounds
|
EP2019830A4
(en)
|
2006-05-04 |
2011-01-19 |
Inst Hepatitis & Virus Res |
INHIBITORS OF THE SECRETION OF HEPATITIS B VIRUS ANTIGENS FOR THE TREATMENT OF A CHRONIC HEPATITIS VIRUS
|
US8153803B2
(en)
|
2006-07-18 |
2012-04-10 |
The General Hospital Corporation |
Compositions and methods for modulating sirtuin activity
|
US20080021063A1
(en)
|
2006-07-18 |
2008-01-24 |
Kazantsev Aleksey G |
Compositions and methods for modulating sirtuin activity
|
FR2903985B1
(fr)
|
2006-07-24 |
2008-09-05 |
Sanofi Aventis Sa |
Derives de n-(amino-heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
|
FR2904316B1
(fr)
|
2006-07-31 |
2008-09-05 |
Sanofi Aventis Sa |
Derives de n-(amino-heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique.
|
US20100016310A1
(en)
|
2006-08-17 |
2010-01-21 |
Boehringer Ingelheim International Gmbh |
Methods of using aryl sulfonyl compounds effective as soluble epoxide hydrolase inhibitors
|
US20100113421A1
(en)
|
2006-10-06 |
2010-05-06 |
Williams Theresa M |
Non-nucleoside reverse transcriptase inhibitors
|
EP2091527B1
(en)
|
2006-12-13 |
2016-03-23 |
Temple University - Of The Commonwealth System of Higher Education |
Sulfide, sulfoxide and sulfone chalcone analogues, derivatives thereof and therapeutic uses thereof
|
US8071779B2
(en)
|
2006-12-18 |
2011-12-06 |
Inspire Pharmaceuticals, Inc. |
Cytoskeletal active rho kinase inhibitor compounds, composition and use
|
US20100022517A1
(en)
|
2006-12-18 |
2010-01-28 |
Richards Lori A |
Ophthalmic formulation of rho kinase inhibitor compound
|
FR2910473B1
(fr)
|
2006-12-26 |
2009-02-13 |
Sanofi Aventis Sa |
Derives de n-(amino-heteroaryl)-1h-pyrrolopyridine-2- carboxamides, leur preparation et leur application en therapeutique.
|
JP2008179621A
(ja)
|
2006-12-28 |
2008-08-07 |
Taisho Pharmaceutical Co Ltd |
含窒素飽和複素環化合物
|
JP2008184403A
(ja)
|
2007-01-29 |
2008-08-14 |
Japan Health Science Foundation |
新規c型肝炎ウイルス阻害剤
|
PE20090188A1
(es)
|
2007-03-15 |
2009-03-20 |
Novartis Ag |
Compuestos heterociclicos como moduladores de la senda de hedgehog
|
US8097728B2
(en)
|
2007-04-30 |
2012-01-17 |
Philadelphia Health & Education Corporation |
Iminosugar compounds with antiflavirus activity
|
BRPI0811516A2
(pt)
|
2007-05-04 |
2014-11-18 |
Irm Llc |
Compostos e composições como inibidores de c-kit e pdgfr cinase
|
WO2008154819A1
(fr)
|
2007-06-18 |
2008-12-24 |
Zhang, Zhongneng |
Thiazolyl-dihydropyrimidines à substitution carbéthoxy
|
US8597949B2
(en)
|
2007-07-28 |
2013-12-03 |
The University Of Chicago |
Methods and compositions for modulating RAD51 and homologous recombination
|
BRPI0815038A2
(pt)
|
2007-08-02 |
2015-03-17 |
Hoffmann La Roche |
Uso de derivados de benzamida para o tratamento de transtornos do cns
|
CN101429166B
(zh)
|
2007-11-07 |
2013-08-21 |
上海特化医药科技有限公司 |
喹唑啉酮衍生物及其制备方法和用途
|
WO2009086303A2
(en)
|
2007-12-21 |
2009-07-09 |
University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
FR2926554B1
(fr)
|
2008-01-22 |
2010-03-12 |
Sanofi Aventis |
Derives de carboxamides azabicycliques, leur preparation et leur application en therapeutique
|
FR2926556B1
(fr)
|
2008-01-22 |
2010-02-19 |
Sanofi Aventis |
Derives de carboxamides n-azabicycliques, leur preparation et leur application en therapeutique
|
FR2926555B1
(fr)
|
2008-01-22 |
2010-02-19 |
Sanofi Aventis |
Derives bicycliques de carboxamides azabicycliques, leur preparation et leur application en therapeutique
|
FR2926553B1
(fr)
|
2008-01-23 |
2010-02-19 |
Sanofi Aventis |
Derives d'indole-2-carboxamides et d'azaindole-2- carboxamides substitues par un groupe silanyle, leur preparation et leur application en therapeutique
|
CU20080028A6
(es)
|
2008-02-29 |
2011-02-24 |
Ct Ingenieria Genetica Biotech |
Compuestos químicos obtenidos in silico para la preparación de composiciones farmacéuticas para atenuar o inhibir la infección por virus dengue y otros flavivirus
|
WO2009146013A1
(en)
|
2008-03-31 |
2009-12-03 |
Georgetown University |
Myosin light chain phosphatase inhibitors
|
AU2009239116B2
(en)
|
2008-04-24 |
2013-05-30 |
Msd K.K. |
Long-chain fatty acid elongation enzyme inhibitor comprising arylsulfonyl derivative as active ingredient
|
US20090325960A1
(en)
|
2008-06-26 |
2009-12-31 |
Fulcher Emilee H |
Method for treating inflammatory diseases using rho kinase inhibitor compounds
|
US20100008968A1
(en)
|
2008-06-26 |
2010-01-14 |
Lampe John W |
Method for treating cardiovascular diseases using rho kinase inhibitor compounds
|
US8207195B2
(en)
|
2008-06-26 |
2012-06-26 |
Inspire Pharmaceuticals, Inc. |
Method for treating neurological and neuropathic diseases using rho kinase inhibitor compounds
|
WO2009158587A1
(en)
|
2008-06-26 |
2009-12-30 |
Inspire Pharmaceuticals, Inc. |
Method for treating pulmonary diseases using rho kinase inhibitor compounds
|
US20090325959A1
(en)
|
2008-06-26 |
2009-12-31 |
Vittitow Jason L |
Method for treating ophthalmic diseases using rho kinase inhibitor compounds
|
US8410147B2
(en)
|
2008-06-26 |
2013-04-02 |
Inspire Pharmaceuticals, Inc. |
Method for treating diseases associated with alterations in cellular integrity using Rho kinase inhibitor compounds
|
EP2321268A2
(en)
|
2008-08-15 |
2011-05-18 |
F. Hoffmann-La Roche AG |
Bi-aryl aminotetralines
|
WO2010027996A1
(en)
|
2008-09-02 |
2010-03-11 |
Institute For Hepatitis And Virus Research |
Novel imino sugar derivatives demonstrate potent antiviral activity and reduced toxicity
|
US8143269B2
(en)
|
2008-10-03 |
2012-03-27 |
Calcimedica, Inc. |
Inhibitors of store operated calcium release
|
WO2010043592A1
(en)
|
2008-10-15 |
2010-04-22 |
Revotar Biopharmaceuticals Ag |
Lipase inhibitors for use for the treatment of obesity
|
UY32251A
(es)
|
2008-11-20 |
2010-05-31 |
Glaxosmithkline Llc |
Compuestos quimicos
|
WO2010065782A1
(en)
|
2008-12-04 |
2010-06-10 |
Inspire Pharmaceuticals, Inc. |
Method for treating pulmonary diseases using rho kinase inhibitor compounds
|
WO2010078430A1
(en)
|
2008-12-30 |
2010-07-08 |
Arqule, Inc. |
Substituted 1h-pyrazolo[3,4-d]pyrimidine-6-amine compounds
|
WO2010088000A2
(en)
|
2009-02-02 |
2010-08-05 |
Angion Biomedica Corp. |
Antifibrotic compounds and uses thereof
|
WO2010123139A1
(ja)
|
2009-04-24 |
2010-10-28 |
持田製薬株式会社 |
スルファモイル基を有するアリールカルボキサミド誘導体
|
JP2012527414A
(ja)
|
2009-05-19 |
2012-11-08 |
バイエル・クロップサイエンス・アーゲー |
殺虫性アリールピロリン
|
CA3080983C
(en)
|
2009-05-27 |
2023-02-28 |
Pct Therapeutics, Inc. |
Method of inhibiting and reducing a viral infection
|
KR20120049852A
(ko)
|
2009-06-30 |
2012-05-17 |
시가 테크놀로지스, 인크. |
뎅기 바이러스 감염의 치료 및 예방
|
US8703938B2
(en)
|
2009-09-11 |
2014-04-22 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
US8822700B2
(en)
|
2009-09-11 |
2014-09-02 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
US20120252792A1
(en)
|
2009-09-17 |
2012-10-04 |
The Regents Of The University Of Michigan |
Methods and compositions for modulating rho-mediated gene transcription
|
WO2011058766A1
(en)
|
2009-11-16 |
2011-05-19 |
Raqualia Pharma Inc. |
Aryl carboxamide derivatives as ttx-s blockers
|
CN102093320B
(zh)
|
2009-12-09 |
2013-08-28 |
扬子江药业集团上海海尼药业有限公司 |
一种可溶性环氧化物水解酶抑制剂
|
EP2523936A1
(en)
|
2010-01-15 |
2012-11-21 |
Boehringer Ingelheim International GmbH |
Compounds which modulate the cb2 receptor
|
WO2011088561A1
(en)
|
2010-01-20 |
2011-07-28 |
University Of Manitoba |
Anti-viral compounds and compositions
|
US20130045203A1
(en)
|
2010-03-02 |
2013-02-21 |
Emory University |
Uses of Noscapine and Derivatives in Subjects Diagnosed with FAP
|
WO2011112191A1
(en)
|
2010-03-11 |
2011-09-15 |
Bristol-Myers Squibb Company |
Compounds for the treatment of hepatitis c
|
CN102206172B
(zh)
|
2010-03-30 |
2015-02-25 |
中国医学科学院医药生物技术研究所 |
一组取代双芳基化合物及其制备方法和抗病毒应用
|
US20130018039A1
(en)
|
2010-03-31 |
2013-01-17 |
Bodmer Vera Q |
Imidazolyl-imidazoles as kinase inhibitors
|
PT2566327T
(pt)
|
2010-05-07 |
2017-05-26 |
Glaxosmithkline Llc |
Indoles
|
WO2011155898A1
(en)
|
2010-06-11 |
2011-12-15 |
Wadell Goeran |
New antiviral compounds
|
US20130142827A1
(en)
|
2010-06-25 |
2013-06-06 |
Philadelphia Health & Education Corporation D/B/A |
Induction of immune response
|
CN103052406A
(zh)
|
2010-07-19 |
2013-04-17 |
印斯拜尔药品股份有限公司 |
双官能rho激酶抑制剂化合物、组合物及应用
|
JP2013536178A
(ja)
|
2010-07-26 |
2013-09-19 |
ニューロセラピューティクス ファーマ, インコーポレイテッド |
アリールスルホンアミド誘導体、組成物、および使用方法
|
BR112013001015A2
(pt)
|
2010-07-27 |
2016-05-24 |
Inspire Pharmaceuticals Inc |
método por tratar doenças oftálmicas que usam compostos de inibidor de cinase em formas de prodrug
|
WO2012016133A2
(en)
|
2010-07-29 |
2012-02-02 |
President And Fellows Of Harvard College |
Ros1 kinase inhibitors for the treatment of glioblastoma and other p53-deficient cancers
|
WO2012033956A1
(en)
|
2010-09-08 |
2012-03-15 |
Mithridion, Inc. |
Cognition enhancing compounds and compositions, methods of making, and methods of treating
|
WO2012047856A2
(en)
|
2010-10-04 |
2012-04-12 |
Institute For Hepatitis And Virus Research |
Novel inhibitors of secretion of hepatitis b virus antigens
|
GB201017345D0
(en)
|
2010-10-14 |
2010-11-24 |
Proximagen Ltd |
Receptor antagonists
|
US8912195B2
(en)
|
2010-12-02 |
2014-12-16 |
Bristol-Myers Squibb Company |
Alkyl amides as HIV attachment inhibitors
|
WO2012080050A1
(en)
|
2010-12-14 |
2012-06-21 |
F. Hoffmann-La Roche Ag |
Solid forms of a phenoxybenzenesulfonyl compound
|
GB201103419D0
(pt)
|
2011-02-28 |
2011-04-13 |
Univ Aberdeen |
|
RS57758B1
(sr)
|
2011-04-08 |
2018-12-31 |
Janssen Sciences Ireland Uc |
Pirimidinski derivati za tretman viralnih infekcija
|
US8889716B2
(en)
|
2011-05-10 |
2014-11-18 |
Chdi Foundation, Inc. |
Transglutaminase TG2 inhibitors, pharmaceutical compositions, and methods of use thereof
|
WO2013006394A1
(en)
|
2011-07-01 |
2013-01-10 |
Institute For Hepatitis And Virus Research |
Sulfamoylbenzamide derivatives as antiviral agents against hbv infection
|
EA037918B1
(ru)
|
2011-12-21 |
2021-06-07 |
Новира Терапьютикс, Инк. |
Противовирусные агенты против гепатита в
|
UY34566A
(es)
|
2012-01-06 |
2013-07-31 |
Janssen R & D Ireland |
1,4?dihidropirimidinas 4,4?disustituidas y su uso como medicamentos para el tratamiento de la hepatitis b
|
NZ631419A
(en)
|
2012-02-29 |
2017-03-31 |
Baruch S Blumberg Inst |
Inhibitors of hepatitis b virus covalently closed circular dna formation and their method of use
|
WO2013144129A1
(en)
|
2012-03-31 |
2013-10-03 |
F. Hoffmann-La Roche Ag |
Novel 4-methyl-dihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
|
US20130267517A1
(en)
|
2012-03-31 |
2013-10-10 |
Hoffmann-La Roche Inc. |
Novel 4-methyl-dihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
|
EA027929B1
(ru)
|
2012-05-25 |
2017-09-29 |
Янссен Сайенсиз Айрлэнд Юси |
Нуклеозиды на основе урацила и спирооксетана
|
BR112014029697A2
(pt)
|
2012-06-01 |
2017-08-08 |
Baruch S Blumberg Inst |
método para modular a transcrição de cccdna de hepatite b em um indivíduo, método para modular dna circular covalentemente fechado de vírus da hepatite b e composto
|
JO3300B1
(ar)
|
2012-06-06 |
2018-09-16 |
Novartis Ag |
مركبات وتركيبات لتعديل نشاط egfr
|
AR092348A1
(es)
|
2012-07-11 |
2015-04-15 |
Hoffmann La Roche |
DERIVADOS DE ARIL-SULTAMO COMO MODULADORES DE RORc
|
PL2890683T3
(pl)
|
2012-08-28 |
2017-06-30 |
Janssen Sciences Ireland Uc |
Pochodne skondensowanego bicyklicznego sulfamylu i ich zastosowanie jako leki do leczenia wirusowego zapalenia wątroby typu B
|
UA123256C2
(uk)
|
2012-08-28 |
2021-03-10 |
ЯНССЕН САЙЄНСІЗ АЙРЛЕНД ЮСі |
Сульфамоїлариламіди та їх застосування як лікарських препаратів для лікування гепатиту b
|
MA37942B1
(fr)
|
2012-09-10 |
2020-01-31 |
Hoffmann La Roche |
Hétéroaryldihydropyrimidines d'acide 6-aminé pour le traitement et la prophylaxie d'une infection par le virus de l'hépatite b
|
BR112015015584A2
(pt)
|
2012-12-27 |
2017-12-12 |
Baruch S Blumberg Inst |
novos agentes antivirais contra infecção por hbv
|
HUE034820T2
(en)
|
2013-02-28 |
2018-02-28 |
Janssen Sciences Ireland Uc |
Sulphamoyl arylamides and their use as medicaments for the treatment of hepatitis B
|
UA114950C2
(uk)
|
2013-02-28 |
2017-08-28 |
Ейсей Р Енд Д Менеджмент Ко., Лтд. |
ТЕТРАГІДРОІМІДАЗО[1,5-d][1,4]ОКСАЗЕПІНОВА ПОХІДНА
|
WO2014165128A2
(en)
|
2013-03-12 |
2014-10-09 |
Novira Therapeutics, Inc. |
Hepatitis b antiviral agents
|
WO2014151958A1
(en)
|
2013-03-14 |
2014-09-25 |
VenatoRx Pharmaceuticals, Inc. |
Beta-lactamase inhibitors
|
ES2640063T3
(es)
|
2013-04-03 |
2017-10-31 |
Janssen Sciences Ireland Uc |
Derivados de n-fenil-carboxamida y su uso como medicamentos para el tratamiento de la hepatitis B
|
US9266904B2
(en)
|
2013-05-17 |
2016-02-23 |
Hoffmann-La Roche Inc. |
6-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection
|
AU2014267235B2
(en)
|
2013-05-17 |
2017-10-05 |
Janssen Sciences Ireland Uc |
Sulphamoylthiophenamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
|
JO3603B1
(ar)
|
2013-05-17 |
2020-07-05 |
Janssen Sciences Ireland Uc |
مشتقات سلفامويل بيرولاميد واستخدامها كادوية لمعالجة التهاب الكبد نوع بي
|
US9688681B2
(en)
|
2013-05-28 |
2017-06-27 |
Bayer Cropscience Aktiengesellschaft |
Heterocyclic compounds as pest control agents
|
WO2014191726A1
(en)
|
2013-05-28 |
2014-12-04 |
Astrazeneca Ab |
Chemical compounds
|
WO2014198880A1
(en)
|
2013-06-14 |
2014-12-18 |
Ferrer Internacional, S.A. |
2-(2-aminophenoxy)-3-chloronaphthalene-1,4-dione compounds having orexin 2 receptor agonist activity
|
JP6348978B2
(ja)
|
2013-07-25 |
2018-06-27 |
ヤンセン・サイエンシズ・アイルランド・ユーシー |
グリオキサミド置換ピロールアミド誘導体およびb型肝炎を処置するための医薬品としてのその使用
|
WO2015057945A1
(en)
|
2013-10-18 |
2015-04-23 |
Indiana University Research And Technology Corporation |
Hepatitis b viral assembly effectors
|
WO2015055764A1
(en)
|
2013-10-18 |
2015-04-23 |
Syngenta Participations Ag |
3-methanimidamid-pyridine derivatives as fungicides
|
ES2655518T3
(es)
|
2013-10-23 |
2018-02-20 |
Janssen Sciences Ireland Uc |
Derivados de carboxamida y su uso como medicamentos para el tratamiento de la hepatitis B
|
ES2777248T3
(es)
|
2013-11-14 |
2020-08-04 |
Novira Therapeutics Inc |
Derivados de azepano y métodos de tratar infecciones por hepatitis B
|
JO3466B1
(ar)
|
2013-12-20 |
2020-07-05 |
Takeda Pharmaceuticals Co |
مواد ضابطة لتترا هيدرو بيريدوبيرازينات من gpr6
|
US9169212B2
(en)
|
2014-01-16 |
2015-10-27 |
Novira Therapeutics, Inc. |
Azepane derivatives and methods of treating hepatitis B infections
|
US9181288B2
(en)
|
2014-01-16 |
2015-11-10 |
Novira Therapeutics, Inc. |
Azepane derivatives and methods of treating hepatitis B infections
|
BR112016017808B1
(pt)
|
2014-01-31 |
2022-07-12 |
Cognition Therapeutics, Inc |
Composto ou sal farmaceuticamente aceitável, uso de um composto e composição para a inibição de um efeito betaamilóide numa célula neuronal
|
KR20160128305A
(ko)
|
2014-02-05 |
2016-11-07 |
노비라 테라퓨틱스, 인코포레이티드 |
Hbv 감염의 치료를 위한 병용 요법
|
CN110483484A
(zh)
|
2014-02-06 |
2019-11-22 |
爱尔兰詹森科学公司 |
氨磺酰基吡咯酰胺衍生物及其作为药物用于治疗乙型肝炎的用途
|
DK3114128T3
(en)
|
2014-03-07 |
2019-03-25 |
Hoffmann La Roche |
New 6-fused heteroaryld dihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection
|
RS59430B1
(sr)
|
2014-03-13 |
2019-11-29 |
Univ Indiana Res & Tech Corp |
Alosterni modulatori proteina jezgra hepatitisa b
|
US9400280B2
(en)
|
2014-03-27 |
2016-07-26 |
Novira Therapeutics, Inc. |
Piperidine derivatives and methods of treating hepatitis B infections
|
MX2016012573A
(es)
|
2014-03-28 |
2018-02-19 |
Sunshine Lake Pharma Co Ltd |
Compuestos de dihidropirimidina y su aplicacion en productos farmaceuticos.
|
EP3150600B1
(en)
|
2014-05-30 |
2018-06-27 |
Qilu Pharmaceutical Co., Ltd. |
Dihydropyrimido loop derivative as hbv inhibitor
|
CA2969557A1
(en)
|
2014-12-02 |
2016-06-09 |
Novira Therapeutics, Inc. |
Sulfide alkyl and pyridyl reverse sulfonamide compounds for hbv treatment
|
US9518057B2
(en)
|
2014-12-30 |
2016-12-13 |
Novira Therapeutics, Inc. |
Derivatives and methods of treating hepatitis B infections
|
MA41338B1
(fr)
|
2015-01-16 |
2019-07-31 |
Hoffmann La Roche |
Composés de pyrazine pour le traitement de maladies infectieuses
|
US9884831B2
(en)
|
2015-03-19 |
2018-02-06 |
Novira Therapeutics, Inc. |
Azocane and azonane derivatives and methods of treating hepatitis B infections
|
WO2016161268A1
(en)
|
2015-04-01 |
2016-10-06 |
Enanta Pharmaceuticals, Inc. |
Hepatitis b antviral agents
|
EP3283472B1
(en)
|
2015-04-17 |
2021-04-14 |
Indiana University Research & Technology Corporation |
Hepatitis b viral assembly effectors
|
WO2016183266A1
(en)
|
2015-05-13 |
2016-11-17 |
Enanta Pharmaceuticals, Inc. |
Ehpatitis b antiviral agents
|
US10875876B2
(en)
|
2015-07-02 |
2020-12-29 |
Janssen Sciences Ireland Uc |
Cyclized sulfamoylarylamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
|
EP3356328A1
(en)
|
2015-09-29 |
2018-08-08 |
Novira Therapeutics, Inc. |
Crystalline forms of a hepatitis b antiviral agent
|
CN109251212A
(zh)
|
2017-07-14 |
2019-01-22 |
上海长森药业有限公司 |
内环硫醚酰胺-芳基酰胺类化合物及其治疗乙型肝炎的用途
|